No Data
No Data
Cellectar Falls After Updating Pivotal Data for Lead Asset
Top Premarket Decliners
Express News | Cellectar Biosciences Shares Are Trading Lower. The Company Announced Results From Its CLOVER WaM Pivotal Study Evaluating Iopofosine I 131
Express News | Cellectar Biosciences Inc: Plan to Submit Nda in Q4
Express News | Cellectar Biosciences Inc - Iopofosine I 131 Was Well Tolerated and Its Toxicity Profile Was Consistent With Company's Previously Reported Safety Data.
Express News | Cellectar Biosciences: Median Dor in Patients Achieving Major Response and Overall Response Were Not Reached as of Data Cutoff in Study
No Data
joeyboulevard : trying to get in since 2.38. difficult
TrytosaveabitOP joeyboulevard: Are you using limit or market order
joeyboulevard TrytosaveabitOP: limit
TrytosaveabitOP joeyboulevard: K! Yup PM and AM you need to use limit! I
joeyboulevard TrytosaveabitOP: but looks a tad scary now. on 2nd thought![rolling_on_the_floor_laughing 🤣](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f923.png)
View more comments...